Results 21 to 30 of about 55,639 (278)

Endovascular Treatment of Epistaxis

Seminars in interventional radiology, 2020
Epistaxis is not uncommon, with up to 60% of the population suffering from at least one episode in their lifetime and as many as 6% presenting for medical attention.
J. Wojak
semanticscholar   +1 more source

Association of Hypertension With the Risk and Severity of Epistaxis.

JAMA Otolaryngology - Head and Neck Surgery, 2020
Importance The association between hypertension and epistaxis has long been a subject of debate. Objectives To evaluate the risk of epistaxis in patients with hypertension using a nationwide population cohort and to assess the association of ...
Hayoung Byun, J. Chung, Seung Hwan Lee, Jiin Ryu, Changsun Kim, J. Shin   +5 more
semanticscholar   +1 more source

Development and Validation of the Nasal Outcome Score for Epistaxis in Hereditary Hemorrhagic Telangiectasia (NOSE HHT).

JAMA Otolaryngology - Head and Neck Surgery, 2020
Importance Epistaxis is the greatest cause of morbidity in patients with hereditary hemorrhagic telangiectasia (HHT); because of this, a validated epistaxis-specific quality-of-life instrument for HHT should be made available.
Andrew Peterson, D. Kallogjeri, E. Spitznagel, Murali M Chakinala, J. Schneider, J. Piccirillo   +5 more
semanticscholar   +1 more source

Hospitalization for epistaxis: a population-based healthcare research study in Thuringia, Germany

European Archives of Oto-Rhino-Laryngology, 2020
Purpose Epistaxis is the most common ENT emergency. The aim was to determine population-based data on severe epistaxis needing inpatient treatment. Methods Retrospective population-based cohort study in the federal state Thuringia in 2016 performed on ...
M. Kallenbach, A. Dittberner, D. Boeger, J. Buentzel, H. Kaftan, K. Hoffmann, P. Jecker, A. Mueller, G. Radtke, O. Guntinas-Lichius   +9 more
semanticscholar   +1 more source

Sphenopalatine-sphenopalatine anastomosis: a unique cause of intractable epistaxis, safely treated with microcatheter embolization: a case report

Journal of Medical Case Reports, 2007
Epistaxis is the most common emergency presenting to the ENT surgeon. Here we present a case of epistaxis arising from the sphenopalatine artery in a patient who had previously had the ipsilateral external carotid artery ligated due to previous epistaxis.
Kamani Tawakir, Shaw Simon, Ali Ahmed, Manjaly George, Jeffree Martin   +4 more
doaj   +1 more source

Efficacy of Timolol in a Novel Intranasal Thermosensitive Gel for Hereditary Hemorrhagic Telangiectasia-Associated Epistaxis: A Randomized Clinical Trial.

JAMA Otolaryngology - Head and Neck Surgery, 2020
Importance Other than nasal moisturizers, no standard-of-care medical therapy exists for epistaxis in hereditary hemorrhagic telangiectasia (HHT).
Andrew Peterson, Jake J. Lee, D. Kallogjeri, J. Schneider, Murali M Chakinala, J. Piccirillo   +5 more
semanticscholar   +1 more source

Endoscopic Cauterization of Sphenopalatine Artery in Posterior Epistaxis- Our Experience

Bengal Journal of Otolaryngology and Head Neck Surgery, 2015
Introduction Epistaxis is one of the commonest emergencies in Otorhinolaryngology. The management of intractable posterior epistaxis sometime becomes challenging to ENT surgeons.
Mukesh Kumar Singh, Chiranjib Das, Dwaipayan Mukherjee, Anirudhha Majumder, Tapan Kanti Hazra   +4 more
doaj   +3 more sources

Nephrogenic epistaxis [PDF]

Singapore Medical Journal, 2014
Metastatic renal cell carcinoma (RCC) in the nose and paranasal sinuses is very rare. We report an unusual case of metastatic RCC that presented as recurrent epistaxis ten years after curative nephrectomy. The purpose of this report is to draw the attention of clinicians to the possibility of metastatic RCC in patients with recurrent epistaxis and ...
Rajeev, Kumar, Kapil, Sikka, Rakesh, Kumar, Priti, Chatterjee   +3 more
openaire   +2 more sources

Topical Propranolol Improves Epistaxis Control in Hereditary Hemorrhagic Telangiectasia (HHT): A Randomized Double-Blind Placebo-Controlled Trial

Journal of Clinical Medicine, 2020
Epistaxis is a common debilitating manifestation in hereditary hemorrhagic telangiectasia (HHT), due to mucocutaneous telangiectases. The epistaxis can be difficult to control despite available treatments.
M. Mei-Zahav, Y. Gendler, E. Bruckheimer, D. Prais, E. Birk, M. Watad, N. Goldschmidt, E. Soudry   +7 more
semanticscholar   +1 more source

Efficacy and Safety of a 0.1% Tacrolimus Nasal Ointment as a Treatment for Epistaxis in Hereditary Hemorrhagic Telangiectasia: A Double-Blind, Randomized, Placebo-Controlled, Multicenter Trial

Journal of Clinical Medicine, 2020
Hereditary hemorrhagic telangiectasia is a rare but ubiquitous genetic disease. Epistaxis is the most frequent and life-threatening manifestation and tacrolimus, an immunosuppressive agent, appears to be an interesting new treatment option because of its
S. Dupuis-Girod, A. Fargeton, V. Grobost, S. Riviére, M. Beaudoin, E. Decullier, L. Bernard, V. Bréant, Bettina Colombet, P. Philouze, S. Bailly, F. Faure, R. Hermann   +12 more
semanticscholar   +1 more source